Artiva Biotherapeutics, Inc. (ARTV)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch ARTV
See up to 3 months of ARTV. The 7-day demo opens the 1M and 3M ranges and puts ARTV on your watchlist.
Start 7-day demoLatest ARTV insider trades
Fred Aslan - OfficerOpen-market sale$169K- Christopher Horan - OfficerOpen-market sale$71K
About Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. files with the SEC under CIK 0001817241 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
ARTV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 8 | 512,027 | $4.88M |
| Open-market sale | 12 | 218,793 | $2.00M |
| Grant or award | 24 | 1,045,000 | |
ARTV insider transactions (Form 4)
3771 Form 4 filings on record, the earliest from Oct 22, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Fred Aslan - Officer | Open-market sale | Common Stock | 23,463 | $7.20 footnote F2 | $169K | |
| ||||||
| Christopher Horan - Officer | Open-market sale | Common Stock | 10,340 footnote F1 | $6.84 | $71K | |
| ||||||
| Jennifer Bush - Officer | Open-market sale | Common Stock | 8,370 footnote F1 | $6.84 | $57K | |
| ||||||
| Subhashis Banerjee - Officer | Open-market sale | Common Stock | 1,099 footnote F1 | $6.84 | $8K | |
| ||||||
| Fred Aslan - Officer | Open-market sale | Common Stock | 61,696 footnote F1 | $6.84 | $422K | |
| ||||||
| Fred Aslan - Officer | Grant or award | Common Stock | 45,000 footnote F1 | $0.00 | - | |
| Fred Aslan - Officer | Grant or award | Employee Stock Option (Right to Buy) | 155,000 | $0.00 | - | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
 Laura Stoppel - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
| Elaine K. Sorg - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
| Elizabeth L. Hougen - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
| Brian Daniels - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
| Daniel G. Baker - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
 Alison Moore - Director | Grant or award | Director Stock Option (Right to Buy) | 16,250 | $0.00 | - | |
| Gines Diego Miralles - Officer | Grant or award | Common Stock | 45,000 footnote F1 | $0.00 | - | |
| Gines Diego Miralles - Officer | Grant or award | Employee Stock Option (Right to Buy) | 135,000 | $0.00 | - | |
| ||||||
| Christopher Horan - Officer | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| Christopher Horan - Officer | Grant or award | Employee Stock Option (Right to Buy) | 120,000 | $0.00 | - | |
| ||||||
| Jennifer Bush - Officer | Grant or award | Common Stock | 45,000 footnote F1 | $0.00 | - | |
| Jennifer Bush - Officer | Grant or award | Employee Stock Option (Right to Buy) | 135,000 | $0.00 | - | |
| ||||||
| Subhashis Banerjee - Officer | Grant or award | Common Stock | 30,000 footnote F1 | $0.00 | - | |
| Subhashis Banerjee - Officer | Grant or award | Employee Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| ||||||
| Fred Aslan - Officer | Open-market sale | Common Stock | 23,429 | $10.92 footnote F2 | $256K | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Laura Stoppel - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Elaine K. Sorg - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Elizabeth L. Hougen - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Brian Daniels - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Daniel G. Baker - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Alison Moore - Director | Grant or award | Director Stock Option (Right to Buy) | 13,750 | $0.00 | - | |
| Christopher Horan - Officer | Open-market sale | Common Stock | 10,366 footnote F1 | $11.16 footnote F2 | $116K | |
| ||||||
| Jennifer Bush - Officer | Open-market sale | Common Stock | 8,391 footnote F1 | $11.16 footnote F2 | $94K | |
| ||||||
| Subhashis Banerjee - Officer | Open-market sale | Common Stock | 1,100 footnote F1 | $11.16 | $12K | |
| ||||||
| Fred Aslan - Officer | Open-market sale | Common Stock | 61,888 footnote F1 | $11.16 footnote F2 | $690K | |
| ||||||
| Subhashis Banerjee - Officer | Option exercise | Common Stock | 5,306 | $1.92 | $10K | |
| Subhashis Banerjee - Officer | Open-market sale | Common Stock | 8,222 | $12.01 footnote F2 | $99K | |
| Subhashis Banerjee - Officer | Option exercise | Employee Stock Option (Right to Buy) | 5,306 | $0.00 | - | |
| ||||||
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Item 8.01
Item 5.02
Recent ARTV Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| FRED ASLAN | Director, Officer | 34,465 | $246K | View on EDGAR | |
| FRED ASLAN | Director, Officer | 23,429 |
ARTV insider trading FAQ
What is the latest insider trade for ARTV?
Artiva Biotherapeutics, Inc. (ARTV) had 35 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for ARTV runs to 71 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ARTV stock?
8 insider purchases of ARTV were filed in the last 90 days, totaling $4.88M.
How many insiders are selling ARTV stock?
12 insider sales of ARTV were filed in the last 90 days, totaling $2.00M.
Where can I see ARTV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ARTV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Fred Aslan view on EDGAR
- - Christopher Horan view on EDGAR
- - Jennifer Bush view on EDGAR
- - Subhashis Banerjee view on EDGAR
- - Fred Aslan view on EDGAR
- - Fred Aslan view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Laura Stoppel view on EDGAR
- - Elaine K. Sorg view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ARTV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ARTV with a 7-day demo
- ARTV on your watchlist
- Every ARTV Form 4 filing on record
- Up to 3 months of ARTV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
